human | Q5 |
P213 | ISNI | 0000000140469784 |
P8980 | KANTO ID | 000048602 |
P244 | Library of Congress authority ID | n2011184310 |
P496 | ORCID iD | 0000-0001-9794-9797 |
P214 | VIAF ID | 187275142 |
P10832 | WorldCat Entities ID | E39PBJB8rbtwhCj74JD7fqMXVC |
P27 | country of citizenship | Finland | Q33 |
P108 | employer | University of Eastern Finland | Q2093139 |
P734 | family name | Kosma | Q37518857 |
Kosma | Q37518857 | ||
Kosma | Q37518857 | ||
P735 | given name | Veli-Matti | Q56856923 |
Veli-Matti | Q56856923 | ||
P106 | occupation | researcher | Q1650915 |
P39 | position held | full professor | Q25339110 |
P21 | sex or gender | male | Q6581097 |
Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
Q33848895 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy |
Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
Q57250674 | A common coding variant in CASP8 is associated with breast cancer risk |
Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
Q37192589 | A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication |
Q40283249 | A highly reproducible xenograft model for human ovarian carcinoma and application of MRI and ultrasound in longitudinal follow-up |
Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
Q35870483 | A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients |
Q55043120 | A recurrent mutation in PALB2 in Finnish cancer families. |
Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
Q36748207 | Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review |
Q45869391 | Adenovirus-mediated gene transfer into an experimental pancreatic tumour. |
Q40656016 | Adenovirus‐mediated VEGF‐A gene transfer induces bone formationin vivo |
Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
Q42107698 | Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer |
Q45878085 | Angiographically guided utero-placental gene transfer in rabbits with adenoviruses, plasmid/liposomes and plasmid/polyethyleneimine complexes |
Q35681656 | Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis |
Q39396206 | Antiangiogenic gene therapy with soluble VEGF-receptors -1, -2 and -3 together with paclitaxel prolongs survival of mice with human ovarian carcinoma |
Q33713224 | Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice |
Q72549891 | Apoptosis in breast cancer as related to histopathological characteristics and prognosis |
Q71512317 | Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis |
Q52597929 | Application of morphometry in tumor pathology. |
Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
Q33828680 | Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival |
Q53399411 | Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. |
Q37292963 | Association of ESR1 gene tagging SNPs with breast cancer risk |
Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
Q74336375 | Azaserine-induced rat pancreas tumor model with transplantable cultured cells |
Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
Q45871985 | Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods |
Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
Q73014289 | Bone recovery after a gluten-free diet: a 5-year follow-up study |
Q68016552 | Breast cancer in young women: clinical, histological and morphometric prognostic factors |
Q34327945 | Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 |
Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
Q37406868 | Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functions |
Q28183827 | CD44 expression indicates favorable prognosis in epithelial ovarian cancer |
Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
Q57278920 | CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population |
Q40846389 | Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer |
Q67943157 | Clinical, histological and quantitative prognostic factors in cutaneous malignant melanoma |
Q43843779 | Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk |
Q45867642 | Combined Gene Therapy Using AdsVEGFR2 and AdsTie2 With Chemotherapy Reduces the Growth of Human Ovarian Cancer and Formation of Ascites in Mice |
Q39540928 | Combined respiratory effects of cold air with SO(2) or NO(2) in repeated 10-minute exposures of hyperventilating guinea pigs |
Q73953743 | Combined respiratory effects of cold air with SO(2) or NO(2) in single 1-hour exposures of hyperventilating guinea pigs |
Q35891162 | Common breast cancer susceptibility loci are associated with triple-negative breast cancer |
Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q73093379 | Comparison of classic and quantitative prognostic factors in colorectal cancer |
Q70595710 | Comparison of classic and quantitative prognostic factors in hormone receptor-positive and hormone receptor-negative female breast cancer |
Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q74016824 | Correlation of MIB-1 antigen expression with transcription factors Skn-1, Oct-1, AP-2, and HPV type in cervical intraepithelial neoplasia |
Q68147612 | DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer |
Q44176489 | DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer |
Q28345021 | Decline after immobilisation and recovery after remobilisation of synovial fluid IL1, TIMP, and chondroitin sulphate levels in young beagle dogs |
Q34497238 | Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer |
Q35803454 | Diffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs. Whole Tumor Regions of Interest |
Q72374800 | Distribution and short-term effects of intratracheally instilled neutron-irradiated UO2 particles in the rat |
Q39790048 | Dose and time dependency of inflammatory responses in the mouse lung to urban air coarse, fine, and ultrafine particles from six European cities |
Q43245651 | Downregulated CD44 and hyaluronan expression in vulvar intraepithelial neoplasia and squamous cell carcinomas |
Q37238492 | Downregulation of p21/WAF1 is related to advanced and dedifferentiated laryngeal squamous cell carcinoma |
Q50857224 | Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma. |
Q74178212 | Effects of 50 Hz magnetic fields on UV-induced skin tumourigenesis in ODC-transgenic and non-transgenic mice |
Q73757441 | Effects of 50 Hz magnetic fields on cancer induced by ionizing radiation in mice |
Q39650770 | Effects of mobile phone radiation on UV-induced skin tumourigenesis in ornithine decarboxylase transgenic and non-transgenic mice. |
Q54357747 | Effects of mobile phone radiation on X-ray-induced tumorigenesis in mice. |
Q71171651 | Effects of simulated nuclear fuel particles on the histopathology and CYP enzymes in the rat lung and liver |
Q45228871 | Elevated expression of hyaluronan and its CD44 receptor in the duodenal mucosa of coeliac patients |
Q44220730 | Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors. |
Q57250672 | Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk |
Q42520511 | Ethylenethiourea and nabam induced alterations of function and morphology of thyroid gland in rats |
Q73322203 | Evaluation of p21WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer. Finbladder Group |
Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
Q38462298 | Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer |
Q73336751 | Expression and prognostic value of alpha-, beta-, and gamma-catenins indifferentiated thyroid carcinoma |
Q31789296 | Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer |
Q53435467 | Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. |
Q42467180 | Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up |
Q47345941 | Expression of HER2 and its association with AP-2 in breast cancer |
Q73676491 | Expression of activator protein 2 in prostate cancer is related to tumor differentiation and cell proliferation |
Q24297789 | Expression of betaglycan, an inhibin coreceptor, in normal human ovaries and ovarian sex cord-stromal tumors and its regulation in cultured human granulosa-luteal cells |
Q71986141 | Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival |
Q41975154 | Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival |
Q44836609 | Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer |
Q73841951 | Expression of hyaluronan in benign and malignant breast lesions |
Q42457364 | Expression of hyaluronan in normal and dysplastic bronchial epithelium and in squamous cell carcinoma of the lung |
Q33444259 | Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content |
Q73364825 | Expression of inducible nitric oxide synthase in colorectal cancer and its association with prognosis |
Q34372081 | Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis |
Q43996199 | Expression of p53 and p21 Ki-ras proteins in rat thyroid gland tumors induced by 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX). |
Q70872949 | Expression of p53 protein has no independent prognostic value in breast cancer |
Q72326571 | Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival |
Q35399244 | Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation |
Q36620965 | Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer |
Q64929653 | Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer. |
Q53514045 | Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. |
Q37394076 | FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome |
Q42683589 | FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population |
Q42153252 | Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2alpha in cutaneous melanoma |
Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
Q57278925 | Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas |
Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
Q57305903 | Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility |
Q54395614 | GASC1 expression in lung carcinoma is associated with smoking and prognosis of squamous cell carcinoma. |
Q54617426 | Gene dose effect of the DQB1*0201 allele contributes to severity of coeliac disease. |
Q33589487 | Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes |
Q33197201 | Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p. |
Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
Q24645441 | Genome-wide association study identifies novel breast cancer susceptibility loci |
Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
Q56903217 | Genomewide search and association studies in a Finnish celiac disease population: Identification of a novel locus and replication of the HLA and CTLA4 loci |
Q43575811 | Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. |
Q43871398 | Gonadotrophins inhibit the expression of insulin-like growth factor binding protein-related protein-2 mRNA in cultured human granulosa-luteal cells |
Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
Q36547888 | Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers |
Q51450789 | High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome. |
Q73383737 | High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer |
Q44022340 | High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer |
Q43582728 | High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer |
Q35770507 | High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma |
Q44565959 | Histological assessment of the prognostic factors in female breast cancer |
Q34475807 | Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer |
Q53811641 | Histopathological and morphometrical analysis applied to skin changes in NMRI mice induced by dithranol (anthranil) and its acyl analogs. |
Q58244337 | Hormone Receptors as Prognostic Factors in Female: Breast Cancer |
Q67819119 | Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma |
Q39458163 | Human carotid arteries: correlation of intravascular US with angiographic and histopathologic findings |
Q43856146 | Hyaluronan expression in differentiated thyroid carcinoma |
Q36617504 | Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate |
Q37158644 | Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan |
Q35745456 | Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival |
Q33704516 | Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma |
Q44168152 | Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival |
Q42435892 | Hyaluronan, CD44 and versican in epidermal keratinocyte tumours |
Q54569063 | Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. |
Q41931639 | Hypermethylation of the WT1 and calcitonin gene promoter regions at chromosome 11p in human colorectal cancer |
Q73081830 | Hypothyroidism after radiotherapy for laryngeal cancer |
Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
Q36014067 | Identification of novel genetic markers of breast cancer survival |
Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
Q44430058 | Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer |
Q38458827 | Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer |
Q30710606 | Inducible nitric oxide synthase expression in pharyngeal squamous cell carcinoma: relation to p53 expression, clinicopathological data, and survival |
Q34202917 | Inflammatory potential of the spores of Penicillium spinulosum isolated from indoor air of a moisture-damaged building in mouse lungs |
Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
Q74593307 | Irregular expression of hyaluronan and its CD44 receptor is associated with metastatic phenotype in laryngeal squamous cell carcinoma |
Q73639317 | Is the subsite distribution of laryngeal cancer related to smoking habits? |
Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
Q36375268 | KDM4A, KDM4B and KDM4C in non-small cell lung cancer |
Q41581759 | KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes |
Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
Q71820008 | Life‐long over‐expression of ornithine decarboxylase (ODC) gene in transgenic mice does not lead to generally enhanced tumorigenesis or neuronal degeneration |
Q74495363 | Lipid peroxidation products and antioxidant capacity in portal venous and systemic arterial plasma during gradual intestinal ischemia and reperfusion in pigs |
Q73263784 | Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables |
Q35642678 | Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival |
Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
Q68044525 | Lymphocyte infiltrates as a prognostic variable in female breast cancer |
Q58769239 | Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls |
Q47736522 | Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella |
Q72797532 | Mast cells in breast cancer |
Q51015419 | Matriptase-2 gene (TMPRSS6) variants associate with breast cancer survival, and reduced expression is related to triple-negative breast cancer. |
Q36619164 | Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women |
Q73480107 | Merkel cell carcinoma of the auricle |
Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
Q41923291 | Mitotic indexes as prognostic predictors in female breast cancer |
Q36292687 | Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma |
Q42706074 | MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen |
Q31147360 | Morphometric analysis of the small intestine in wild type mice C57BL/6L -- a developmental study. |
Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
Q24811182 | Mycobacterium terrae isolated from indoor air of a moisture-damaged building induces sustained biphasic inflammatory response in mouse lungs |
Q46567991 | NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer |
Q45194389 | NAT2 slow acetylator genotype as an important modifier of breast cancer risk |
Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
Q34594981 | No observed local immunological response at cell level after five years of oats in adult coeliac disease |
Q73216234 | Non-suppressed thyrotropin and elevated thyroglobulin are independent predictors of recurrence in differentiated thyroid carcinoma |
Q74690696 | Nuclear and cytoplasmic p53 expression in pharyngeal squamous cell carcinoma: prognostic implications |
Q35397312 | Nuclear beta catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma |
Q33495389 | Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression |
Q42601584 | Nuclear morphometry and DNA flow cytometry as prognostic factors in female breast cancer |
Q73158896 | Nuclear morphometry as a predictor of disease outcome in gastric cancer |
Q69015163 | Observer variation in interactive computerized morphometry |
Q44257284 | Obstetric prognosis after placental abruption |
Q55032863 | Osteoporosis in adult patients with celiac disease. |
Q34351474 | Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer |
Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
Q34289136 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche |
Q27851443 | Penetrance analysis of the PALB2 c.1592delT founder mutation |
Q36873786 | Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q57278958 | Polymorphic catechol-O-methyltransferase gene and breast cancer risk |
Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
Q44021268 | Potential of nuclear morphometry and volume-corrected mitotic index in grading transitional cell carcinoma of the urinary bladder. |
Q44569490 | Preclinical safety, toxicology, and biodistribution study of adenoviral gene therapy with sVEGFR-2 and sVEGFR-3 combined with chemotherapy for ovarian cancer |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q67881188 | Prediction of outcome after first recurrence of breast cancer |
Q70532790 | Predictive value of a morphometric prognostic index in female breast cancer |
Q43968046 | Preoperative angiopoietin-2 serum levels: a marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer |
Q57278972 | Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer |
Q41261406 | Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI. |
Q44930415 | Primary malignant schwannoma of the small bowel |
Q36180689 | Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer |
Q68108346 | Prognostic factors after 5 years follow-up in female breast cancer |
Q67839931 | Prognostic factors in axillary lymph node-negative (pN−) breast carcinomas |
Q36135969 | Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration |
Q45828735 | Prognostic factors in gastric carcinoma - reply. |
Q68071260 | Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer |
Q35769582 | Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer |
Q73236066 | Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy |
Q71985955 | Prognostic value of cathepsin-D expression in female breast cancer |
Q32159926 | Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma |
Q73828602 | Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer |
Q47756115 | Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic beta-catenin in Min mice |
Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
Q40077918 | Pulmonary inflammation and tissue damage in the mouse lung after exposure to PM samples from biomass heating appliances of old and modern technologies |
Q64361230 | Quantitation of staining for amyloid in histological sections: sources of variation, correlation analysis, and interstain reproducibility |
Q114182625 | Rare germline copy number variants (CNVs) and breast cancer risk |
Q57278973 | Receiver-operating characteristic (ROC) curve analysis of cathepsin D and pS2 in breast disease; results from a prospective study |
Q73131535 | Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma |
Q73028633 | Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma |
Q37229463 | Reduced expression of alpha catenin is associated with poor prognosis in colorectal carcinoma |
Q35398680 | Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer |
Q38449110 | Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma |
Q51803936 | Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma. |
Q35829460 | Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma |
Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
Q28301674 | Refinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish population |
Q68954346 | Reproducibility and variation of morphometric analysis of carcinoembryonic antigen staining in histopathology. The influence of standardized microscopic fields |
Q53896112 | Reproducibility of morphometric measurements of amyloid after various staining methods. |
Q45951126 | Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. |
Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
Q50849173 | SIP1 predicts progression and poor prognosis in pharyngeal squamous cell carcinoma. |
Q36545934 | SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival |
Q42934843 | ST14 gene variant and decreased matriptase protein expression predict poor breast cancer survival |
Q34307873 | SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer? |
Q69243410 | Sampling in diagnostic morphometry: the influence of variation sources |
Q72159127 | Sapphire probe versus bare fiber in interstitial laser hyperthermia (ILH). An experimental study with Wistar rats |
Q34266010 | Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer |
Q57278977 | Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer |
Q45174545 | Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer |
Q44231576 | Spores of Aspergillus versicolor isolated from indoor air of a moisture-damaged building provoke acute inflammation in mouse lungs |
Q52891526 | Standardized mitotic counts in breast cancer. Evaluation of the method. |
Q30580197 | Stent placement versus percutaneous transluminal angioplasty of human carotid arteries in cadavers in situ: distal embolization and findings at intravascular US, MR imaging and histopathologic analysis |
Q40731645 | Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. |
Q44100252 | Supraglottic and glottic carcinomas. clinically and biologically distinct entities? |
Q33566957 | TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer |
Q50218828 | Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups. |
Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
Q36917100 | The UGT1A6_19_GG genotype is a breast cancer risk factor |
Q68170597 | The changing importance of prognostic factors in breast cancer during long-term follow-up |
Q71740242 | The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer |
Q59344240 | The incidence and etiology of postlaryngectomy pharyngocutaneous fistulae |
Q30884328 | The morphological changes in rat bladder after photodynamic therapy with 5-aminolaevulinic acid-induced protoporphyrin IX. |
Q74128967 | The prognostic value of inducible nitric oxide synthase in local prostate cancer |
Q38964801 | The reciprocal association between mammographic breast density, hyaluronan synthesis and patient outcome |
Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
Q45278364 | The significance of nuclear morphometric variables as prognostic predictors in breast cancer |
Q68751013 | Toxicity of richterite in hemolysis test and macrophage cultures |
Q43850081 | Transcription factor snail1 expression and poor survival in pharyngeal squamous cell carcinoma |
Q33821467 | Transcription factors zeb1, twist and snai1 in breast carcinoma |
Q74093456 | Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer |
Q47419710 | Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer |
Q33990838 | Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression |
Q38428338 | Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impact |
Q33910850 | Type II transmembrane serine protease gene variants associate with breast cancer |
Q33932788 | Verrucous carcinoma of the anus containing human papillomavirus type 16 DNA detected by in situ hybridisation: a case report |
Q44594532 | Versican in epithelial ovarian cancer: Relation to hyaluronan, clinicopathologic factors and prognosis |
Q45265824 | Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis |
Q28258209 | Very low mammographic breast density predicts poorer outcome in patients with invasive breast cancer |
Q50592574 | Vimentin-ERK Signaling Uncouples Slug Gene Regulatory Function. |
Q44843638 | Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk |
Q25257811 | XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study |
Q57278886 | XRCC1 rs25487 polymorphism predicts the survival of patients after postoperative radiotherapy and adjuvant chemotherapy for breast cancer |
Q70186783 | [Cardiac amyloidosis] |
Q74500692 | [Primary malignant melanoma of the larynx] |
Q51021180 | alpha-, beta- and chi-catenin expression in human pancreatic cancer. |
Q36618938 | p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival |
Q36619342 | p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer |
Q36641213 | p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis |
Q33918416 | p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women |
Q73690528 | p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma |
Q44118215 | p53-independent apoptosis in UV-irradiated mouse skin: possible inhibition by 50 Hz magnetic fields |
Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
Q28534781 | Γ-secretase components as predictors of breast cancer outcome |
Search more.